138 related articles for article (PubMed ID: 11313686)
1. Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
Leone F; Perissinotto E; Viale A; Cavalloni G; Taraglio S; Capaldi A; Piacibello W; Torchio B; Aglietta M
Bone Marrow Transplant; 2001 Mar; 27(5):517-23. PubMed ID: 11313686
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
3. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
5. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
6. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
[TBL] [Abstract][Full Text] [Related]
8. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
9. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
10. [Mammaglobin mRNA measurement in the detection of micrometastasis in peripheral blood of breast cancer patients].
Liu N; Zhang W; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):317-9. PubMed ID: 11783116
[TBL] [Abstract][Full Text] [Related]
11. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
[TBL] [Abstract][Full Text] [Related]
12. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.
Krüger WH; Stockschläder M; Hennings S; Aschenbrenner M; Gruber M; Gutensohn K; Löliger C; Gieseking F; Jonat W; Zander AR
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S18-20. PubMed ID: 8899163
[TBL] [Abstract][Full Text] [Related]
13. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
[TBL] [Abstract][Full Text] [Related]
15. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
16. Mammaglobin: a candidate diagnostic marker for breast cancer.
Zehentner BK; Carter D
Clin Biochem; 2004 Apr; 37(4):249-57. PubMed ID: 15003725
[TBL] [Abstract][Full Text] [Related]
17. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
[TBL] [Abstract][Full Text] [Related]
18. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
20. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
